Nebenwirkungen · NexoBrid
NexoBrid 5 g powder and gel for gel · Abschnitt 4.8 · PDF-Seite 9
HOS-213907 · Präparat HOS-155226
Wound complications Wound complications reported include the following: wound deepening, wound desiccation, wound re- opening, graft loss/ graft failure. In pooled adult populations from phase 2 and 3 studies including studies pre- and post-implementation of antibacterial soaking (MW2001, MW2002, MW2004, MW2005, MW2008, and MW2010) including 280 patients treated with this medicinal product and 179 patients treated with SOC, the following incidences were reported (medicinal product vs. SOC): wound complication: 3.2% vs. 1.7%, wound decomposition: 1.1% vs. 0.6%, skin graft failure/graft loss 2.9% vs 2.2% .
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-03T16:44:00Z · SHA-256 0e966e92cc19adf0ef382cd0ae4ca84db51705148a696b737819286b20db4bab · Passage 0c4cca950ed944815480968468ad6844c2d67ca7706b7ba2406d3bafb50ae1cd · Zeichen 4259–4870 im Abschnitt